Expression and clinical significance of EGFL7 in malignant glioma
Authors:
- 6 March 2010
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 136 (11) , 1737-1743
Abstract
Tumor angiogenesis is an important factor for the continuous growth of human malignancies and can be used to predict the prognosis for patients. In the current study, we examined the expression of EGF-like domain 7 (EGFL7), an endothelial cell-derived secreted factor, in malignant gliomas and explored its clinical significance. We determined the steady-state mRNA levels of EGFL7 from 36 fresh glioma samples by semi-quantitative RT–PCR and the protein levels from 45 paraffin-embedded glioma samples by immunohistochemistry, respectively. Normal brain tissues from 10 patients with brain trauma were used as control. We also analyzed the correlations between the expression levels of EGFL7 and various clinical parameters, including patient gender, age, tumor grade, tumor proliferation marker Ki-67, and microvessel density (MVD). We found that EGFL7 was not detectable in normal brain tissues, but was up-regulated in both tumor cells and vascular endothelial cells within malignant glioma. The expression level of EGFL7 in malignant glioma significantly correlated with the tumor grade, Ki-67 expression and MVD (P < 0.01). Our data suggest that EGFL7 expression is a novel predictive factor for the clinical progression of malignant glioma, and may constitute a therapeutic target for anti-angiogenesis therapy in patients with the disease.Keywords
This publication has 23 references indexed in Scilit:
- miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7Biochemical and Biophysical Research Communications, 2010
- Egfl7 knockdown causes defects in the extension and junctional arrangements of endothelial cells during zebrafish vasculogenesisDevelopmental Dynamics, 2008
- Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell deathAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Molecularly targeted therapy for malignant gliomaCancer, 2007
- Expression of Ki‐67, Topoisomerase IIα and c‐MYC in astrocytic tumors: Correlation with the histopathological grade and proliferative statusNeuropathology, 2006
- Angiogenesis in malignant glioma—A target for antitumor therapy?Critical Reviews in Oncology/Hematology, 2006
- Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomasJournal of neurosurgery. Pediatrics, 2006
- Genetic Pathways to GlioblastomaCancer Research, 2004
- The Hallmarks of CancerCell, 2000
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI: Journal of the National Cancer Institute, 1992